Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017, Boston University School of Medicine

African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

The findings appear in the journal Cancer Research.

Evidence has emerged in recent years that the two major subtypes of —estrogen receptor positive (ER+) and estrogen receptor negative (ER-) —differ in some causes. Thus, the investigators focused on whether type 2 had differing associations with ER+ and ER- cancer.

The research was based on data of 54,337 African American women enrolled in Boston University's Black Women's Health Study who were cancer free at enrollment in the study in 1995 and were followed for up to 18 years. During follow-up, 914 ER+ cases and 468 ER- cases were identified.

African American women with type 2 diabetes were estimated to have a 43 percent increase in risk of ER- breast cancer relative to women without diabetes; in contrast, there was no increase in the risk of ER+ breast cancer among women with diabetes relative to women without diabetes. The increased risk of ER- breast cancer among women with diabetes was not explained by obesity status.

"While we observed no association for the most common type of breast cancer, the type that is responsive to estrogens, women with diabetes were estimated to be at increased risk of developing estrogen receptor negative breast cancer, a more aggressive type of breast cancer which is twice as common in U.S. black women as in white women," explained corresponding author Julie Palmer, ScD, associate director of Boston University's Slone Epidemiology Center, professor of epidemiology at Boston University School of Public Health, and associate director for population sciences at the BU-BMC Cancer Center.

According to Palmer plausible explanations for an increased risk of ER- breast cancer among women with diabetes include chronic inflammation resulting from diabetes which, among other actions, can promote carcinogenic processes. "Given that the prevalence of diabetes is twice as high in African Americans as in whites, the current finding, if confirmed, may help to explain the higher incidence of ER- breast cancer in African American ."

Explore further: Pregnancy poses no greater risk to breast cancer survivors

Related Stories

Pregnancy poses no greater risk to breast cancer survivors

October 26, 2017
A recent study published in the Journal of the National Cancer Institute indicates that pregnancy does not incur a greater risk of relapse for survivors of breast cancer. The safety of pregnancy for women with history of ...

Childbearing may increase risk of hormone receptor-negative breast cancer in African-American women

August 16, 2011
African-American women are at higher risk for hormone receptor-negative breast cancer, one of the most difficult subtypes to treat, but this risk could be ameliorated somewhat by breast-feeding their children.

Researchers identify breast cancer risk factors for younger, black women

October 19, 2016
Black women under the age of 45 are at increased risk for an aggressive form of breast cancer [estrogen receptor (ER) negative] if they experienced a high number of pregnancies, never breast fed, and/or had higher waist-to-hip ...

Breast cancer risk reduced in women with diabetes who take low-dose aspirin

June 8, 2017
A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not. The study design and results are published ...

Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk

September 16, 2014
Women who have had children (parous women) appear to have an increased risk of developing estrogen receptor-negative breast cancer, the subtype that carries a higher mortality rate and is more common in women of African ancestry. ...

Female hormone supplements with estrogen and progestin linked to breast cancer risk

November 30, 2015
Postmenopausal African American women who use female hormone supplements containing estrogen and progestin ("combination" therapy) are at an increased risk for estrogen receptor positive breast cancer.

Recommended for you

Sequencing genomes of Nigerian women could help prevent many lethal breast cancers

August 21, 2018
For the first time, DNA contributed by Sub-Saharan African women has been thoroughly evaluated with innovative genomics technology in an effort to understand the genetic bases for breast cancer in African populations.

First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy

August 21, 2018
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling ...

Scientists take step toward new, targeted lung cancer treatment

August 21, 2018
Scientists have identified a key molecular player in a subtype of lung cancer which could lead to a new way to tackle the disease, according to research published in Nature Communications.

New compound advances into Phase 1 trial for pancreatic cancer

August 21, 2018
A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cancer. Called CEND-1 (scientifically known as iRGD), the compound was exclusively ...

Simple test could identify bladder cancer patients who won't respond to immunotherapy

August 21, 2018
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School (BSMS).

Annual pap test a 'thing of the past?'

August 21, 2018
The United States Preventive Services Task Force (USPSTF) has released new recommendations on screening for cervical cancer. These latest recommendations continue the trend of decreasing participant burden by lengthening ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.